Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Novel small molecule activators of the NLRP3 inflammasome as immunostimulants

Objetivo

We have identified a novel family of potent small molecule activators of the NLRP3 inflammasome. The goal of this project is to determine the feasibility of developing these new immunostimulators into an attractive commercial proposition. Establishment of technical feasibility will involve identification the most promising modifications of our drug candidates and testing their efficacy in disease models of cancer and immunization. In addition, we will determine commercial feasibility by conducting market research and competition analysis and by engaging potential industry partners.

Régimen de financiación

ERC-POC - Proof of Concept Grant

Institución de acogida

UNIVERSITAETSKLINIKUM FREIBURG
Aportación neta de la UEn
€ 150 000,00
Dirección
HUGSTETTER STRASSE 49
79106 Freiburg
Alemania

Ver en el mapa

Región
Baden-Württemberg Freiburg Freiburg im Breisgau, Stadtkreis
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
Sin datos

Beneficiarios (1)